Figure 2.
Blockade of IL-6 signals by anti-IL-6 receptor antibody (MRA, Tocilizumab). h, human;
IL, interleukin; sIL-6R, soluble interleukin-6 receptor.
Kishimoto Arthritis Research & Therapy 2006 8(Suppl 2):S2 doi:10.1186/ar1916